Latest News

The 4% rule is a helpful estimate, but a three-layer income plan shows exactly where your next retirement payment comes from.

The best investments are sometimes the simplest.

Bird Construction stock has delivered impressive gains. Here’s how its growing project pipeline could support the next phase of infrastructure growth.

The 2026 TSX30 list features five Canadian technology companies whose average return reached an extraordinary 981%.

This under-the-radar consumer discretionary stock boasts a Superscore of 80 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.

Executives from Bitcoin mining and digital infrastructure companies said access to energized power, land and data-center development capabilities is creating an opportunity to serve growing artificial intelligence infrastructure demand, while also presenting significant construction, financing and r

Recent pullbacks have created potential opportunities in several quality TSX stocks. Other than dividends, they also offer potential upside if their valuations recover.

How important are terrestrial data centers to SpaceX in the near term?

Defense engineering surged 68% as marine tech declined, reshaping revenue mix.

Scotiabank (BNS) stock offers Canadian banking’s top yield at 3.5%. Here’s how quarterly dividend compounding can snowball your returns over time.

The management team did enough to alleviate some investors' fears about worst-case scenarios for the business.

Revenue is catching up to an expensive valuation.

Investors are skeptical about these optimistic forecasts.

Archer Aviation is one of those high-risk, high-reward type investments.

This stock should only be considered by investors with a high risk tolerance.

AI agents can take more actions than humans, creating increasing demands for cybersecurity.

Customer deposits are helping offset cash flow needs at Oracle.

Demand might fall in the future, but shortages remain for now.

The move could boost consumer spending, while also increasing inflationary pressures.

Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis said the company has progressed from the initial phase of its “Pivot to Growth” plan into its next stage, citing momentum in branded medicines, innovation, generics and biosimilars, as well as improved financial flexibility. Speaking at

These three established Canadian stocks will keep thriving despite Trump’s latest import restrictions and rising trade tensions.

OAS clawbacks can hit retirees who feel “comfortable,” especially when RRIF withdrawals inflate taxable income.

The last four months of the year only have to look something like the four that just ended.

Dave & Buster's Entertainment (NASDAQ:PLAY) reported lower second-quarter revenue and earnings but said same-store sales trends improved during July and the early weeks of its third quarter as the company pursues a “back-to-basics” strategy centered on traffic, value and store execution. Revenu

CRISPR Therapeutics (NASDAQ:CRSP) CEO Sam Kulkarni outlined the company’s commercial and clinical priorities during a Morgan Stanley discussion, highlighting continued adoption of CASGEVY and expected data updates across several pipeline programs by the end of 2026. Kulkarni said the company’s stra